Summary Slide.png (111.98 kB)

Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis

Download (111.98 kB)
posted on 28.08.2020 by Ataru Igarashi, Barnaby Hunt, Lars Wilkinson, Jakob Langer, Richard F. Pollock

The above Summary Slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.